Analysis of SLC40A1 gene at the mRNA level reveals rapidly the causative mutations in patients with hereditary hemochromatosis type IV

Blood Cells, Molecules, and Diseases

Volumn 40, Issue 3, 2008, Pages 353-359

  Speletas, Matthaios ^a   Kioumi, Anna ^b   Loules, Gedeon ^a   Hytiroglou, Prodromos ^c   Tsitouridis, John ^b   Christakis, John ^d   Germenis, Anastasios E ^a  

^a UNIVERSITY OF THESSALY   (Greece)

^b PAPAGEORGIOU GENERAL HOSPITAL   (Greece)

^c ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^d THEAGENIO CANCER HOSPITAL   (Greece)

Author keywords

Ferroportin; Hemochromatosis; NIRCA; RT PCR; SLC40A1

Indexed keywords

IRON; MESSENGER RNA; TRANSFERRIN;

ADULT; AGED; ARTICLE; ASSAY; CASE REPORT; CONTROLLED STUDY; FEMALE; GENE; GENE MUTATION; GENE SEQUENCE; GENETIC ANALYSIS; HEMOCHROMATOSIS; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPERFERRITINEMIA; KUPFFER CELL; MACROPHAGE; MALE; NON ISOTOPIC RNASE CLEAVAGE ASSAY; NUCLEOTIDE SEQUENCE; PEDIGREE ANALYSIS; PHLEBOTOMY; PRIORITY JOURNAL; RELATIVE; RELIABILITY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SENSITIVITY ANALYSIS; SLC40A1 GENE;

ADULT; AGED, 80 AND OVER; CATION TRANSPORT PROTEINS; FEMALE; FERRITINS; GENOTYPE; HEMOCHROMATOSIS; HUMANS; IRON; LIVER; MALE; MIDDLE AGED; MUTATION; RNA, MESSENGER;

EID: 41949088717     PISSN: 10799796     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bcmd.2007.09.011     Document Type: Article

References (30)

1. Pietrangelo A. The ferroportin disease. Blood Cells Mol. Diseases 32 (2004) 131-138
2. De Domenico I., McVey Ward D., Musci G., and Kaplan J. Iron overload due to mutations in ferroportin. Haematologica 91 (2006) 92-95
3. Njajou O.T., Vaessen N., Joosse M., Berghuis B., van Dongen J.W., Breuning M.H., Snijders P.J.L.M., Rutten W.P.F., Sandkuijl L.A., Oostra B.A., van Duijn C.M., and Heutink P. A mutation in SLC11A3 is associated with autosomal dominant hemochromatosis. Nat. Genet. 28 (2001) 213-214
4. Montosi M., Donovan A., Totaro A., Garuti C., Pignatti E., Cassanelli S., Trenor C.C., Gasparini P., Andrews N.C., and Pietrangelo A. Autosomal-dominant hemochromatosis is associated with a mutation in the ferroportin (SLC11A3) gene. J. Clin. Invest. 108 (2001) 619-623
5. Devalia V., Carter K., Walker A.P., Perkins S.J., Worwood M., May A., and Dooley J.S. Autosomal dominant reticuloendothelial iron overload associated with a 3-base pair deletion in the ferroportin1 gene (SLC11A3). Blood 100 (2002) 695-697
6. Roetto A., Merryweather-Clarke A.T., Daraio F., Livesey K., Pointon J.J., Barbabietola G., Piga A., Mackie P.H., Robson K.J.H., and Camaschella C. A valine deletion of ferroportin 1: a common mutation in hemochromatosis type 4?. Blood 100 (2002) 733-734
7. Cazzola M., Cremonesi L., Papaioannou M., Soriani N., Kioumi A., Charalambidou A., Paroni R., Romtsou K., Levi S., Ferrari M., Arosio P., and Christakis J. Genetic hyperferritinaemia and reticuloendothelial iron overload associated with a three base pair deletion in the coding region of the ferroportin gene (SLC11A3). Br. J. Haematol. 119 (2002) 539-546
8. Arden K.E., Wallace D.F., Dixon J.L., Summerville L., Searle J.W., Anderson G.J., Ramm G.A., Powell L.W., and Subramaniam V.N. A novel mutation in ferroportin 1 is associated with haemochromatosis in a Solomon Islands patient. Gut 2 (2003) 1215-1217
9. Beutler E., Barton J.C., Felitti V.J., Gelbart T., West C., Lee P.L., Waalen J., and Vulpe C. Ferroportin 1 (SLC40A1) variant associated with iron overload in African-Americans. Blood Cells Mol. Diseases 31 (2003) 305-309
10. Hetet G., Devaux I., Soufir N., Grandchamp B., and Beaumont C. Molecular analyses of patients with hyperferritinemia and normal serum iron values reveal both L ferritin IRE and 3 new ferroportin (SLC11A3) mutations. Blood 102 (2003) 1904-1910
11. Jouanolle A.M., Douabin-Gicquel V., Halimi C., Loreal O., Fergelot P., Delacour T., De Lajarte-Thirouard A.S., Turlin B., Le Gall J.Y., Cadet E., Rochette J., David V., and Brissot P. Novel mutation in ferroportin 1 gene is associated with autosomal dominant iron overload. J. Hepatol. 39 (2003) 286-289
12. Rivard S.R., Lanzara C., Grimard D., Carell M., Simard H., Ficarell R., Simard R., Pio D'Adamo A., De Braekeller M., and Gasparini P. Autosomal dominant reticuloendothelial iron overload (HFE type 4) due to a new missense mutation in the ferroportin gene (SLC11A3) in a large French-Canadian family. Haematologica 88 (2003) 824-826
13. Wallace D.F., Pedersen P., Dixon J.L., Stephenson P., Searle J.W., Powell L.W., and Subramaniam V.N. Novel mutation in ferroportin 1 is associated with autosomal dominant hemochromatosis. Blood 100 (2002) 692-694
14. Robson K.J.H., Merryweather-Clarke A.T., Cadet E., Viprakasit V., Zaahl M.G., Pointon J.J., Weatherall D.J., and Rochette J. Recent advances in understanding haemochromatosis: a transition state. J. Med. Genet. 41 (2004) 721-730
15. Wallace D.F., Clark R.M., Harley H.A.J., and Subramaniam V.N. Autosomal dominant iron overload due to a novel mutation of ferroportin1 associated with parenchymal iron loading and cirrhosis. J. Hepatol. 40 (2004) 710-713
16. Koyama C., Wakusawa S., Hayashi H., Ueno T., Suzuki R., Yano M., Saito H., and Okazaki T. A Japanese family with ferroportin disease caused by a novel mutation of SLC40A1 gene: hyperferritinemia associated with a relatively low transferrin saturation of iron. Intern. Med. 44 (2005) 990-993
17. Sham R.L., Phataka P.D., Westb C., Leeb P., Andrewsa C., and Beutler E. Autosomal dominant hereditary hemochromatosis associated with a novel ferroportin mutation and unique clinical features. Blood Cells Mol. Diseases 34 (2005) 157-161
18. Gordeuk V.R., Caleffi A., Corradini E., Ferrara F., Jones R.A., Castro O., Onyekwere O., Kittles R., Pignatti E., Montosi G., Garuti C., Gangaidzo I.T., Gomo Z.A.R., Moyo V.M., Rouault T.A., MacPhail P., and Pietrangelo A. Iron overload in Africans and African-Americans and a common mutation in the SCL40A1 (ferroportin 1) gene. Blood Cells Mol. Diseases 31 (2003) 299-304
19. Barton J.C., Acton R.T., Lee P.L., and West C. SLC40A1 Q248H allele frequencies and Q248H-associated risk of non-HFE iron overload in persons of sub-Saharan African descent. Blood Cells Mol. Diseases 39 (2007) 206-211
20. Papazoglou D., Exiara T., Speletas M., Panagopoulos I., and Maltezos E. Prevalence of hemochromato-sis gene (HFE) mutations in Greece. Acta Haematol. 109 (2003) 137-140
21. Goldrick M.M., Kimball G.R., Liu Q., Martin L.A., Sommer S.S., and Tseng J.Y. NIRCA: a rapid robust method for screening for unknown point mutations. Biotechniques 21 (1996) 106-112
22. Liu X.B., Yang F., and Haile D.J. Functional consequences of ferroportin 1 mutations. Blood Cells Mol. Diseases 35 (2005) 33-46
23. Speletas M., Kanariou M., Kanakoudi-Tsakalidou F., Papadopoulou-Alataki E., Arvanitidis K., Pardali E., Constantopoulos A., Kartalis G., Vihinen M., Sideras P., and Ritis K. Analysis of Btk mutations in patients with X-linked agammaglobulinaemia (XLA) and determination of carrier status in normal female relatives: a nationwide study of Btk deficiency in Greece. Scand. J. Immunol. 54 (2001) 321-327
24. Speletas M., Arvanitidis K., Tzoannopoulos D., Tsironidou V., Pardali E., Aggeli C., Tsapogas P., Kartalis G., Sideras P., and Ritis K. Rapid mutational analysis of N-ras proto-oncogene in hematologic malignancies: study of 77 Greek patients. Haematologica 86 (2001) 918-927
25. Tzoanopoulos D., Speletas M., Arvanitidis K., Veiopoulou C., Kyriaki S., Thyphronitis G., Sideras P., Kartalis G., and Ritis K. Low expression of Interferon regulatory factor-1 and identification of novel exons skipping in patients with chronic myeloid leukaemia. Br. J. Haematol. 119 (2002) 46-53
26. Abboud S., and Haile D.J. A novel mammalian iron-regulated protein involved in intracellular iron metabolism. J. Biol. Chem. 275 (2000) 19906-19912
27. McKie A.T., Marciani P., Rolfs A., Brennan K., Wehr K., Barrow D., Miret S., Bomford A., Peters T.J., Farzaneh F., Hediger M.A., Hentze M.W., and Simpson R.J. A novel duodenal iron-regulated transporter, IREG1, implicated in the basolateral transfer of iron to the circulation. Mol. Cell 5 (2000) 299-309
28. Schimanski L.M., Drakesmith H., Merryweather-Clarke A.T., Viprakasit V., Edwards J.P., Sweetland E., Bastin J.M., Cowely D., Chinthammitr Y., Robson K.J.H., and Townsend A.R.M. In vitro functional analysis of human ferroportin (FPN) and hemochromatosis-associated mutations. Blood 105 (2005) 4096-4102
29. De Domenico I., McVey Ward D., Nemeth E., Vaughn M.B., Musci G., Ganz T., and Kaplan J. The molecular basis of ferroportin-linked hemochromatosis. Proc. Natl. Acad. Sci. U. S. A. 102 (2005) 8955-8960
30. Drakesmith H., Schimanski L.M., Ormerod E., Merryweather-Clarke A.T., Viprakasit V., Edwards J.P., Sweetland E., Bastin J.M., Cowley D., Chinthammitr Y., Robson K.J.H., and Townsend A.R.M. Resistance to hepcidin is conferred by hemochromatosis-associated mutations of ferroportin. Blood 106 (2005) 1092-1097